Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
ELTP
$0.28
-2.61%
ELTP
· Elite Pharmaceuticals Inc /Nv/
$0.28
-0.01 (-2.61%)
At close · Sep 1
Going-concern doubt
— flagged Jun 29, 2026
Substantial doubt about the company's ability to continue as a going concern.
“In certain years prior to the fiscal year ended March 31, 2021, the auditor's opinion on our financial statements was qualified with respect to there being substantial doubt as to the Company's ability to continue as a going concern due to continued losses not being sufficiently offset by operating revenues.”View the 10-K filed Jun 29, 2026
Market Cap
$302.68M
Shares
1.08B
All earnings calls
Earnings call · FY2024 Q3
Elite Pharmaceuticals Inc (ELTP) Q3 2024 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$15.54M
+68% YoY
Diluted EPS
$0.00
Gross margin
45.3%
-7.9 pp YoY
Net income
$706,354
-76.2% YoY
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Feb 14, 2024 · complete as-filed document
SEC periodic report
10-Q report
Filed Feb 14, 2024 · complete as-filed document